UAMY News Alert U S Antimony Corp (UAMY) 0.63 02/14/2015 04:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
U S Antimony Corp (UAMY) 0.63 $UAMY

Capital Goods Companies' Quarterly Report Card: New Research on Supreme Industries, Tel-Instrument, U.S. Antimony, UQM Technologies, and Wireless Telecom
PR Newswire - Tue Feb 10, 8:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
WTT: 3.15 (+0.01), UAMY: 0.63 (+0.03), STS: 7.76 (-0.25), UQM: 0.97 (+0.01), TIK: 5.11 (+0.11)

U.S. Antimony Reports Record Production
Business Wire - Tue Nov 18, 7:00AM CST
United States Antimony Corporation ("USAC", NYSE MKT "UAMY" reported it achieved an all time record production of 1,358,518 pounds for the nine months ending September 30, 2014. Meanwhile, Q3 2014 sales were even stronger at 529,129 pounds up 59% from 332,106 pounds the previous quarter.
UAMY: 0.63 (+0.03)

US Antimony signs antimony and gold processing agreement with Hillgrove Mines Pty
M2 - Wed Nov 12, 6:12AM CST
Antimony supplier United States Antimony (NYSE MKT:UAMY) disclosed on Tuesday a major processing agreement for the sale of 200 metric tons per month of 60% antimony concentrates containing about 20 grams per ton (0.64 ounces) of gold to Hillgrove Mines Pty Ltd of Armidale, New South Wales, Australia.
UAMY: 0.63 (+0.03)

U.S. Antimony Reports a Major Processing Agreement
Business Wire - Tue Nov 11, 7:01AM CST
United States Antimony Corporation ("USAC", NYSE MKT "UAMY" reported it has entered a major processing agreement with Hillgrove Mines Pty Ltd of Armidale, New South Wales, Australia for 200 metric tons per month of 60% antimony concentrates containing approximately 20 grams per ton (0.64 ounces) of gold. On a yearly basis, this would amount to approximately 3,000,000 pounds of antimony and 1,500 ounces of gold. The production should give USAC an attractive gross margin on the sale of the antimony and gold. Hillgrove will provide funding to USAC on favorable terms to expand its smelter capacity in Montana and Mexico. Construction will begin immediately and production is expected during Q1 2015. Should Hillgrove decide, the contract also provides for the further expansion of the plant for up to 9,000,000 pounds per year of antimony and 4,500 ounces of gold.
UAMY: 0.63 (+0.03)

U.S. Antimony Announces Investor Conference Call
Business Wire - Fri Nov 07, 2:43PM CST
United States Antimony Corporation ("USAC", NYSE MKT "UAMY" plans to hold an investor call to discuss the 2014 10-Q, and other developments.
UAMY: 0.63 (+0.03)

U.S. Antimony Reports Natural Gas and Increasing Output from Mexican Smelter
Business Wire - Thu Sep 04, 7:00AM CDT
United States Antimony Corporation ("USAC", NYSE MKT "UAMY" reported that natural gas had been turned on at its Mexican Madero Smelter. Natural gas will be approximately seventy percent lower than the cost of propane, and it is expected to significantly increase the gross margin. The Company is also adding four more furnaces that will increase smelter output by 50% and start reducing the inventory of smelter feed. Presently, the smelter is shipping antimony metal of a very high grade similar to Chinese Grade 1. All production is in a sold out status.
UAMY: 0.63 (+0.03)

U.S. Antimony Reports Funding and Increased Antimony Production
Business Wire - Mon Aug 04, 7:01AM CDT
United States Antimony Corporation ("USAC", NYSE MKT "UAMY" has placed 2,453,288 shares at $1.40 with institutional and accredited private investors to raise gross proceeds of $3,434,603. Initial funds are being used to increase Mexican smelting capacity by 50% to process a large inventory of smelter feed in Mexico. Thereafter, funds will be used to further increase smelter production several fold, increase Mexican mine production, resume mining the Los Juarez silver-antimony-gold property, and complete the installation of the 500 ton per day mill.
UAMY: 0.63 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Current Market Sentiment on HealthEquity Shares: A Closer Look

Updated Category News Views 113

Understanding HealthEquity's Short Interest Dynamics HealthEquity Inc (NYSE: HQY) has seen a significant decrease in its short percent of float, which recently dropped by 11.68%. As of the last report, the company had approximately 5.26 million shares sold short, representing 7.03% of its regular shares available for trading. This situation also highlights an average...

Continue Reading
Investors Update: Class Action Against Bumble Inc. Soon

Updated Category News Views 104

Update on Class Action Lawsuit Against Bumble Inc. (BMBL) The Law Offices of Frank R. Cruz are reminding investors about an upcoming significant deadline concerning a class action lawsuit against Bumble Inc. This lawsuit affects investors who acquired BMBL securities during the designated Class Period. Understanding the Class Action Lawsuit The class action was initiated...

Continue Reading
Analysis of Williams-Sonoma's Recent Surge and Current Changes

Updated Category News Views 293

Understanding Williams-Sonoma's Recent Stock Movements This week has seen an impressive rise of nearly 30% in shares of Williams-Sonoma, Inc. (NYSE: WSM), but recent trading indicates a slight pullback. Investors are reacting to two key factors: the natural tendency to take profits and the decision of some buyers to exit losing positions as market conditions evolve. The...

Continue Reading
Understanding the Arconic Corporation Class Action Update

Updated Category News Views 139

Overview of the Class Action Lawsuit Against Arconic Corporation Levi & Korsinsky, LLP has recently announced a class action regarding Arconic Corporation (ARNC). This situation affects investors who may have been impacted by alleged securities fraud. The firm aims to represent those who traded Arconic shares during a specified period and seeks to recover losses resulting...

Continue Reading
Cambrex Partners with Lilly to Enhance Biotech Innovations

Updated Category News Views 220

Cambrex's Strategic Collaboration with Eli Lilly Cambrex, a key player in the global contract development and manufacturing organization (CDMO) sector, has announced an exciting new partnership with Eli Lilly and Company to enhance support for biotech collaborators. Through this agreement, Cambrex aims to provide accelerated access to essential clinical development...

Continue Reading